logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Kardium Inc. raised $104M in new financing led by Fidelity Management & Research Company, T. Rowe Price Associates, Inc., T. Rowe Price Investment Management, Inc., and Durable Capital Partners LP for innovative atrial fibrillation treatment

Jun 11, 2024•over 1 year ago

Amount Raised

$104

Round Type

pre-seed

Vancouver

Investors

Durable Capital Partners LpT. Rowe Price Investment Management, Inc.T. Rowe Price Associates, Inc.Fidelity Management & Research Company

Description

Kardium Inc., developer of the Globe Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $104 million in a new financing round. The round is led by existing investor Fidelity Management & Research Company, together with follow-on participation by funds and accounts advised by T. Rowe Price Associates, Inc. and T

Company Information

Company

Kardium

Location

Vancouver, Washington, United States

About

Kardium Inc. (kardium.com) is a rapidly growing medical solutions company that has developed an advanced system for the treatment of atrial fibrillation: the Globe Mapping and Ablation System. Kardium has built an outstanding team of engineers, medical researchers, compliance and production staff who have worked with top medical advisors to develop the Globe System. Founded in 2007 and headquartered in Vancouver, Canada, Kardium has consistently ranked as one of the top companies to work for in British Columbia.

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech